Top

Published in:

01-05-2008 | Populations at Risk

Racial Segregation and Disparities in Cancer Stage for Seniors

Authors: Jennifer S. Haas, MD, MSPH, Craig C. Earle, MD, John E. Orav, PhD, Phyllis Brawarsky, MPH, Bridget A. Neville, MPH, David R. Williams, PhD, MPH

Published in: Journal of General Internal Medicine | Issue 5/2008

Summary

Background

Disparities in cancer survival may be related to differences in stage. Segregation may be associated with disparities in stage, particularly for cancers for which screening promotes survival.

Objectives

The objective of the study was to examine whether segregation modifies racial/ethnic disparities in stage.

Design

The design of the study was analysis of Surveillance, Epidemiology, and End Results Medicare data for seniors with breast, colorectal, lung, and prostate cancer (n = 410,870).

Measurements and main results

The outcome was early- versus late-stage diagnosis. Area of residence was categorized into 4 groups: low segregation/high income (potentially the most advantaged), high segregation/high income, low segregation/low income, and high segregation/low income (possibly the most disadvantaged). Blacks were less likely than whites to be diagnosed with early-stage breast, colorectal, or prostate cancer, regardless of area. For colorectal cancer, the black/white disparity was largest in low-segregation/low-income areas (black/white odds ratio [OR] of early stage 0.51) and smallest in the most segregated areas (ORs 0.71 and 0.74, P < .005). Differences in disparities in stage by area category were not apparent for breast, prostate, or lung cancer. Whereas there were few Hispanic–white differences in early-stage diagnosis, the Hispanic/white disparity in early-stage diagnosis of breast cancer was largest in low-segregation/low-income areas (Hispanic/white OR of early stage 0.54) and smallest in high-segregation/low-income areas (OR 0.96, P < .05 compared to low-segregation/low-income areas).

Conclusions

Disparities in stages for cancers with an established screening test were smaller in more segregated areas.

Fried VM, Prager K, MacKay AP, Xia H. Chartbook on Trends in the Health of Americans: Health, United States, 2003. Hyattsville, MD: National Center for Health Statistics; 2003.

Ries LAG, Eisner MP, Kosary CL. SEER Cancer Statistics Review, 1973–1999. Bethesda, MD: National Cancer Institute; 2002.

Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347(20):1585–92.PubMedCrossRef

Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med. 2002;162(17):1985–93.PubMedCrossRef

Ragland KE, Selvin S, Merrill DW. Black–white differences in stage-specific cancer survival: analysis of seven selected sites. Am J Epidemiol. 1991;133(7):672–82.PubMed

Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272(12):947–54.PubMedCrossRef

Optenberg SA, Thompson IM, Friedrichs P, Wojcik B, Stein CR, Kramer B. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995;274(20):1599–605.PubMedCrossRef

Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287(16):2106–13.PubMedCrossRef

Oakley-Girvan I, Kolonel LN, Gallagher RP, Wu AH, Felberg A, Whittemore AS. Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients. Am J Public Health. 2003;93(10):1753–9.PubMedCrossRef

10.

McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med. 1998;128(9):729–36.PubMed

11.

Sassi F, Luft HS, Guadagnoli E. Reducing racial/ethnic disparities in female breast cancer: screening rates and stage at diagnosis. Am J Public Health. 2006;96(12):2165–72.PubMedCrossRef

12.

Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163(1):49–56.PubMedCrossRef

13.

Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998;279(22):1801–7.PubMedCrossRef

14.

Lantz PM, Mujahid M, Schwartz K, et al. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health. 2006;96(12):2173–8.PubMedCrossRef

15.

Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.PubMed

16.

Agency for Healthcare Research and Quality. US Preventative Services Task Force. Accessed January 29, 2008, at http://www.ahcpr.gov/clinic/uspstfix.htm.

17.

American Cancer Society. Cancer Facts and Figures. American Cancer Society; 2006. Accessed January 29, 2008, 2006, at http://www.cancer.org/downloads/STT/CAFF2006PWSecured.pdf.

18.

Bach PB, Jett J, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. Jama. 2007;297(9):953–61.PubMedCrossRef

19.

Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355(17):1763–71.PubMedCrossRef

20.

Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. Impact of access and social context on breast cancer stage at diagnosis. J Health Care Poor Underserved. 1995;6(3):342–51.PubMed

21.

Hoffman RM, Gilliland FD, Eley JW, et al. Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2001;93(5):388–95.PubMedCrossRef

22.

Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health. 1991;81(5):646–9.PubMedCrossRef

23.

Bennett CL, Ferreira MR, Davis TC, et al. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol. 1998;16(9):3101–4.PubMed

24.

Margolis ML, Christie JD, Silvestri GA, Kaiser L, Santiago S, Hansen-Flaschen J. Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med. 2003;139(7):558–63.PubMed

25.

Massey DS, Denton NA. Hypersegregation in U.S. metropolitan areas: black and Hispanic segregation along five dimensions. Demography. 1989;26:373–91.PubMedCrossRef

26.

Massey DS. Residential segregation neighborhood conditions in U.S. metropolitan areas. In: Smelser NJ, Wilson WJ, Mitchell F, eds. America Becoming: Racial Trends and Their Consequences. Washington, DC: National Academies; 2001:391–428.

27.

Cutler DM, Glaeser EL, Vigdor JL. Are ghettos good or bad? Q J Econ. 1997;112:827–72.CrossRef

28.

Williams DR, Collins C. Racial residential segregation: a fundamental cause of racial disparities in health. Public Health Rep. 2001;116(5):404–16.PubMed

29.

Chang VW. Racial residential segregation and weight status among US adults. Soc Sci Med. 2006;63(5):1289–303.PubMedCrossRef

30.

Subramanian SV, Acevedo-Garcia D, Osypuk TL. Racial residential segregation and geographic heterogeneity in black/white disparity in poor self-rated health in the US: a multilevel statistical analysis. Soc Sci Med. 2005;60(8):1667–79.PubMedCrossRef

31.

Rodriguez RA, Sen S, Mehta K, Moody-Ayers S, Bacchetti P, O’Hare AM. Geography matters: relationships among urban residential segregation, dialysis facilities, and patient outcomes. Ann Intern Med. 2007;146(7):493–501.PubMed

32.

Massey DS, Denton NA. The dimensions of residential segregation. Soc Forces. 1988;67(2):281. (35 pages).CrossRef

33.

Acevedo-Garcia D, Lochner KA, Osypuk TL, Subramanian SV. Future directions in residential segregation and health research: a multilevel approach. Am J Public Health. 2003;93(2):215–21.PubMedCrossRef

34.

Population Studies Center. Racial Residential Segregation Measurement Project. Population Studies Center, University of Michigan; 2000. Accessed January 29, 2008, at http://enceladus.isr.umich.edu/race/racestart.asp.

35.

Logan JR, Stults BJ, Farley R. Segregation of minorities in the metropolis: two decades of change. Demography. 2004;4111–22.PubMedCrossRef

36.

Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075–9. discussion 81–90.PubMedCrossRef

37.

MacKinnon JA, Duncan RC, Huang Y, et al. Detecting an association between socioeconomic status and late stage breast cancer using spatial analysis and area-based measures. Cancer Epidemiol Biomarkers Prev. 2007;16(4):756–62.PubMedCrossRef

38.

Hughes C, Lerman C, Lustbader E. Ethnic differences in risk perception among women at increased risk for breast cancer. Breast Cancer Res Treat. 1996;40:25–35.PubMedCrossRef

39.

Lawson HW, Henson R, Bobo JK, Kaeser MK. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. Oncology (Williston Park). 2000;14(11)1528–30. 638, 641–2 passim.

40.

Bhargavan M, Sunshine J. Location decisions of mammography facilities: racial/ethnic disparities across zip-codes. In: Proceedings of the Annual Meeting of the Economics of Population Health: Inaugural Conference of the American Society of Health Economists, TBA, Madison, WI, USA, June 4, 2006.

41.

Komaromy M, Grumbach K, Drake M, et al. The role of black and Hispanic physicians in providing health care for underserved populations. N Engl J Med. 1996;334(20):1305–10.PubMedCrossRef

42.

Inagami S, Borrell LN, Wong MD, Fang J, Shapiro MF, Asch SM. Residential segregation and Latino, black and white mortality in New York City. J Urban Health. 2006;83(3):406–20.PubMedCrossRef

43.

Fang J, Madhavan S, Bosworth W, Alderman MH. Residential segregation and mortality in New York City. Soc Sci Med. 1998;47(4):469–76.PubMedCrossRef

44.

Haas JS, Phillips KA, Sonneborn D, et al. Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual’s county of residence. Med Care. 2004;42(7):707–14.PubMedCrossRef

45.

Geronimus AT. To mitigate, resist, or undo: addressing structural influences on the health of urban populations. Am J Public Health. 2000;90(6):867–72.PubMedCrossRef

46.

Halpern D. Minorities and mental health. Soc Sci Med. 1993;365597–607.PubMedCrossRef

47.

Jackson SA, Anderson RT, Johnson NJ, Sorlie PD. The relation of residential segregation to all-cause mortality: a study in black and white. Am J Public Health. 2000;90(4)615–7.PubMedCrossRef

48.

Williams DR. Race, socioeconomic status, and health. The added effects of racism and discrimination. Ann NY Acad Sci. 1999;896(11):173–88.PubMedCrossRef

49.

Darity WA, Jr. Employment discrimination, segregation, and health. Am J Public Health. 2003;93(2):226–31.PubMedCrossRef

50.

Centers for Disease Control and Prevention. Neighborhood safety and the prevalence of physical inactivity–selected states, 1996. MMWR Morb Mortal Wkly Rep. 1999;48(7)143–6.

Title: Racial Segregation and Disparities in Cancer Stage for Seniors
Authors: Jennifer S. Haas, MD, MSPH
Craig C. Earle, MD
John E. Orav, PhD
Phyllis Brawarsky, MPH
Bridget A. Neville, MPH
David R. Williams, PhD, MPH
Publication date: 01-05-2008
Publisher: Springer-Verlag
Published in: Journal of General Internal Medicine / Issue 5/2008
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-008-0545-9

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Racial Segregation and Disparities in Cancer Stage for Seniors

Summary

Background

Objectives

Design

Measurements and main results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Summary

Background

Objectives

Design

Measurements and main results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2008

Discussing Weight with Obese Primary Care Patients: Physician and Patient Perceptions

Primary Versus Specialty Care Outcomes for Depressed Outpatients Managed with Measurement-Based Care: Results from STAR*D

Why Don’t Diabetes Patients Achieve Recommended Risk Factor Targets? Poor Adherence versus Lack of Treatment Intensification

Sexual Intercourse and Risk of Symptomatic Urinary Tract Infection in Post-Menopausal Women

Variations in Practice Guideline Adherence for Abnormal Cervical Cytology in a County Healthcare System

Impact of Fixed-Dose Combination Drugs on Adherence to Prescription Medications

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page